Tenet Healthcare (THC) EVP discloses stock and RSU holdings
Rhea-AI Filing Summary
Tenet Healthcare Corp executive vice president of corporate development Michael T. Maloney filed an initial ownership report showing his equity holdings as of February 27, 2026. The filing lists common stock, performance stock options, and multiple tranches of time-based restricted stock units.
He directly holds common stock and performance stock options from February 2018 and February 2019, along with unvested restricted stock units granted in February 2024, February 2025, and February 2026. The restricted stock units are settled in Tenet common shares upon vesting, with vesting dates running from February 24, 2027 through February 27, 2029. The filing does not show any new purchases or sales, only existing holdings and vesting schedules.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Maloney Michael T.
Role
EVP, Corporate Development
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | 2018 February Performance Stock Options (Right to Buy) | -- | -- | -- |
| holding | 2019 February Performance Stock Options (Right to Buy) | -- | -- | -- |
| holding | 2024 February Restricted Stock Units | -- | -- | -- |
| holding | 2025 February Restricted Stock Units | -- | -- | -- |
| holding | 2026 February Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
2018 February Performance Stock Options (Right to Buy) — 18,876 shares (Direct);
2019 February Performance Stock Options (Right to Buy) — 18,682 shares (Direct);
2024 February Restricted Stock Units — 3,737 shares (Direct);
2025 February Restricted Stock Units — 5,068 shares (Direct);
2026 February Restricted Stock Units — 5,013 shares (Direct);
Common Stock — 101,990 shares (Direct)
Footnotes (4)
- F1. Represents unvested February 2024 time-based restricted stock units that vest in full on February 28, 2027.
- F2. Restricted stock units are settled in shares of the Company's common stock upon vesting.
- F3. Represents unvested February 2025 time-based restricted stock units that vest in equal remaining increments on February 24, 2027, and February 24, 2028.
- F4. Represents unvested February 2026 time-based restricted stock units that vest in one-third increments on February 27, 2027, February 27, 2028, and February 27, 2029.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Tenet Healthcare (THC) Form 3 filing for Michael T. Maloney show?
The Form 3 shows Michael T. Maloney’s existing equity holdings in Tenet Healthcare, including common stock, performance stock options, and unvested restricted stock units. It is an initial ownership report and does not reflect new purchases or sales, only positions and vesting schedules.
What restricted stock units does Michael T. Maloney hold in Tenet Healthcare (THC)?
He holds February 2024, 2025, and 2026 restricted stock units totaling 3,737, 5,068, and 5,013 units, respectively. These are time-based awards that vest on specified future dates, with each unit settling in shares of Tenet’s common stock upon vesting.
When do Michael T. Maloney’s Tenet Healthcare restricted stock units vest?
The February 2024 restricted stock units vest in full on February 28, 2027. The February 2025 units vest in equal remaining increments on February 24, 2027 and February 24, 2028, while the February 2026 units vest in one-third increments from 2027 through 2029.
Are Maloney’s Tenet Healthcare restricted stock units settled in cash or stock?
The Form 3 states that Maloney’s restricted stock units are settled in shares of Tenet Healthcare’s common stock upon vesting. This means that, as each award vests on its scheduled dates, he will receive company shares rather than a cash payment.
Does the Tenet Healthcare (THC) Form 3 indicate insider buying or selling by Michael T. Maloney?
No, the Form 3 does not indicate insider buying or selling. All listed entries are classified as holdings with unknown transaction codes, reflecting existing positions in common stock, stock options, and restricted stock units rather than newly executed purchase or sale transactions.